c-semaglutide 2.5mg/ml Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes Semaglutide / Cyanocobalamin Injection |

10.1016/j.pcd.2016.09.003 [DOI] [PubMed] [Google Scholar] 45

While alopecia is not listed among the adverse reactions in the FDA-approved prescribing information for Ozempic, it is documented in the Wegovy label as occurring at a low frequency and more often than placebo

A large real-world study suggests semaglutide's cardiovascular benefits may be more closely linked to the dose patients receive than to the amount of weight they lose, offering new insight into how the drug may protect heart health

Plaintiffs allege that drug manufacturers did not provide adequate warnings to patients or healthcare providers about these risks

Vaciamiento gstrico: Semaglutida causa un ligero retraso del vaciamiento gstrico en la fase posprandial temprana, disminuyendo en un 31% [13